Treatment of acute tendinitis and bursitis with fentiazac--a double-blind comparison with placebo.
A double-blind comparison of fentiazac and placebo was carried out in 40 adult outpatients with acute nonarticular rheumatism. By random assignment patients received either 100 mg of fentiazac four times a day for one week or an identical-looking placebo in the same dosage. Evaluation was based on improvements in movement-induced pain, pressure-induced pain, and patient's and physician's ratings of therapeutic effect. Fentiazac was significantly better than placebo and produced a similar incidence of side effects, both agents being well tolerated.